A share price of Zevia PBC [ZVIA] is currently trading at $537370.0, up 660946%. An important factor to consider is whether the stock is rising or falling in short-term value. The ZVIA shares have gain 7.64% over the last week, with a monthly amount glided 5.08%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zevia PBC [NYSE: ZVIA] stock has seen the most recent analyst activity on July 25, 2023, when Telsey Advisory Group downgraded its rating to a Market Perform and also revised its price target to $4 from $5. Previously, Goldman downgraded its rating to Neutral on July 25, 2023, and dropped its price target to $3.
Zevia PBC experienced fluctuations in its stock price throughout the past year between $0.62 and $4.99. Currently, Wall Street analysts expect the stock to reach $2.75 within the next 12 months. Zevia PBC [NYSE: ZVIA] shares were valued at $537370.0 at the most recent close of the market. An investor can expect a potential drop of -100.0% based on the average ZVIA price forecast.
Analyzing the ZVIA fundamentals
Trailing Twelve Months sales for Zevia PBC [NYSE:ZVIA] were 154.27M which represents -2.00% decline. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -0.15%, Pretax Profit Margin comes in at -0.15%, and Net Profit Margin reading is -0.13%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -0.29 and Total Capital is -0.6. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Zevia PBC [NYSE:ZVIA] is 2.34. On the other hand, the Quick Ratio is 1.63, and the Cash Ratio is 1.15. Considering the valuation of this stock, the price to sales ratio is 1.49, the price to book ratio is 3.81.
Transactions by insiders
Recent insider trading involved Spence Padraic L., Director, that happened on May 12 ’25 when 75000.0 shares were sold. Director, Spence Padraic L. completed a deal on May 12 ’25 to buy 75000.0 shares. Meanwhile, Officer Taylor Amy bought 29079.0 shares on Mar 18 ’25.
